Redefining Recovery: A Descriptive Phenomenological Study of Elderly Patients’ Lived Experiences with Stem Cell Therapy for Advanced Osteoarthritis

Main Article Content

Aslinda

Abstract

Regenerative medicine offers innovative therapeutic solutions for degenerative diseases such as osteoarthritis, particularly among elderly populations. As populations age globally, osteoarthritis has emerged as a leading cause of disability, significantly impairing mobility and quality of life.While mesenchymal stem cell (MSC) therapy has demonstrated clinical efficacy, little is known about how patients perceive and make sense of their healing experiences. Previous research has largely focused on physiological outcomes, leaving a gap in understanding the subjective, lived experiences of those undergoing regenerative interventions. This study addresses that gap by applying a descriptive phenomenological approach to explore how elderly patients experience MSC therapy for advanced osteoarthritis. Semi-structured interviews were conducted with eight participants aged 60 and above, and data were analyzed using Colaizzi’s method to extract themes that reflect the essence of their experiences. The findings reveal four key themes: regaining lost independence, emotional relief and psychological rebirth, ambivalence toward scientific innovation, and shifting family dynamics and social reintegration. These themes indicate that healing is experienced not only as physical recovery but also as a redefinition of identity and social belonging. The study highlights the need for integrating patient narratives into clinical evaluations to inform more humanistic and holistic care practices. These results contribute to expanding the phenomenological understanding of regenerative therapies and offer a foundation for future qualitative inquiries into the subjective dimensions of medical innovation.

Article Details

Section
Articles

References

Hajj, A., Hachem, R., Khoury, R., Nehme, T., Hallit, S., Nasr, F., Karak, F. E., Chahine, G., Kattan, J., & Khabbaz, L. R. (2021). Clinical and Genetic Factors Associated With the Breast Cancer-Related Sleep Disorders: The “CAGE-Sleep” Study–A Cross-Sectional Study. Journal of Pain and Symptom Management, 62(3), e46–e55. Scopus. https://doi.org/10.1016/j.jpainsymman.2021.02.022

James, J. E., & Joseph, G. (2022). “It’s personalized, but it’s still bucket based”: The promise of personalized medicine vs. The reality of genomic risk stratification in a breast cancer screening trial. New Genetics and Society, 41(3), 228–253. Scopus. https://doi.org/10.1080/14636778.2022.2115348

Lindgren, A., Anttila, M., Rautiainen, S., Arponen, O., Hämäläinen, K., Könönen, M., Vanninen, R., & Sallinen, H. (2019). Dynamic contrast-enhanced perfusion parameters in ovarian cancer: Good accuracy in identifying high HIF-1α expression. PLoS ONE, 14(8). Scopus. https://doi.org/10.1371/journal.pone.0221340

Liskova, A., Samec, M., Koklesova, L., Giordano, F. A., Kubatka, P., & Golubnitschaja, O. (2020). Liquid biopsy is instrumental for 3PM dimensional solutions in cancer management. Journal of Clinical Medicine, 9(9), 1–38. Scopus. https://doi.org/10.3390/jcm9092749

Matrana, M. R., & Campbell, B. (2020). Precision medicine and the institutional review board: Ethics and the genome. Ochsner Journal, 20(1), 98–103. Scopus. https://doi.org/10.31486/toj.19.0098

Mehta, A., Saifi, M., Batra, U., Suryavanshi, M., & Gupta, K. (2020). Incidence of ROS1-rearranged non-small-cell lung carcinoma in India and efficacy of crizotinib in lung adenocarcinoma patients. Lung Cancer: Targets and Therapy, 11, 19–25. Scopus. https://doi.org/10.2147/LCTT.S244366

Oberkampf, F., Gutierrez, M., Trabelsi Grati, O., Rhun, É. L., Trédan, O., Turbiez, I., Kadi, A., Dubot, C., Taillibert, S., Vacher, S., & Bonneau, C. (2023). Phase II study of intrathecal administration of trastuzumab in patients with HER2-positive breast cancer with leptomeningeal metastasis. Neuro-Oncology, 25(2), 365–374. Scopus. https://doi.org/10.1093/neuonc/noac180

Peng, J., Liang, X., & Calderon, L. (2019). Progress in research on gold nanoparticles in cancer management. Medicine (United States), 98(18). Scopus. https://doi.org/10.1097/MD.0000000000015311

Popmihajlov, Z., Sutherland, D. J., Horan, G. S., Ghosh, A., Lynch, D. A., Noble, P. W., Richeldi, L., Reiss, T. F., & Greenberg, S. (2022). CC-90001, a c-Jun N-Terminal kinase (JNK) inhibitor, in patients with pulmonary fibrosis: Design of a phase 2, randomised, placebo-controlled trial. BMJ Open Respiratory Research, 9(1). Scopus. https://doi.org/10.1136/bmjresp-2021-001060

Pratumkaew, P., Issaragrisil, S., & Luanpitpong, S. (2021). Induced pluripotent stem cells as a tool for modeling hematologic disorders and as a potential source for cell-based therapies. Cells, 10(11). Scopus. https://doi.org/10.3390/cells10113250

Protiere, C., Arnold, M., Fiorentino, M., Fressard, L., Lelièvre, J. D., Mimi, M., Raffi, F., Mora, M., Meyer, L., Sagaon-Teyssier, L., Zucman, D., Préau, M., Lambotte, O., Spire, B., Suzan-Monti, M., Bergmann, J. F., Blacher, J., Blanc, A. P., Delobel, P., … Yazdanpanh, Y. (2020). Differences in HIV cure clinical trial preferences of French people living with HIV and physicians in the ANRS-APSEC study: A discrete choice experiment. Journal of the International AIDS Society, 23(2). Scopus. https://doi.org/10.1002/jia2.25443

Riva, S., Bryce, J., De Lorenzo, F., Del Campo, L., Di Maio, M., Efficace, F., Frontini, L., Giannarelli, D., Gitto, L., Iannelli, E., Jommi, C., Montesarchio, V., Traclò, F., Vaccaro, C. M., Gallo, C., & Perrone, F. (2019). Development and validation of a patient-reported outcome tool to assess cancer-related financial toxicity in Italy: A protocol. BMJ Open, 9(9). Scopus. https://doi.org/10.1136/bmjopen-2019-031485

Rosina, E., Rinaldi, B., Silipigni, R., Bergamaschi, L., Gattuso, G., Signoroni, S., Guerneri, S., Carnevali, A., Marchisio, P. G., & Milani, D. (2021). Incidental finding of APC deletion in a child: Double trouble or double chance? – A case report. Italian Journal of Pediatrics, 47(1). Scopus. https://doi.org/10.1186/s13052-021-00969-x

Seguro, F. S., Maciel, F. V. R., Santos, F. M., Abdo, A. N. R., Pereira, T. D. M., Nardinelli, L., Rocha, V., & Bendit, I. (2021). MR 4log and low levels of NK cells are associated with higher molecular relapse after imatinib discontinuation: Results of a prospective trial. Leukemia Research, 101. Scopus. https://doi.org/10.1016/j.leukres.2021.106516

Xulu, K. R., & Augustine, T. N. (2021). Antiplatelet therapy combined with anastrozole induces features of partial emt in breast cancer cells and fails to mitigate breast‐cancer induced hypercoagulation. International Journal of Molecular Sciences, 22(8). Scopus. https://doi.org/10.3390/ijms22084153